Golden Globes host Nikki Glaser shared why she supports people using the injectable drug Ozempic for weight loss, and also ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? The ...

As rates of obesity have increased over the last 20 years, demand for medicines to treat obesity has soared, resulting in ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Their project, called Phytogene, harnesses the power of “biopharming” — a method that transforms plants into living drug ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

Germany-based software company SAP became Europe's most valuable firm on Monday, surpassing Denmark's pharmaceutical company ...

Secret playground Ozempic clubs are evolving as the next trend in dangerous, competitive dieting in schools, eating disorder ...

Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...